Aarey Drugs & Pharmaceuticals Profit & Loss Annual

BSE: 524412 | NSE: AAREYDRUGS | ISIN: INE198H01019 | Sector: Biotechnology & Drugs

55.18 -2.05 (-3.58%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	395.62	418.96	492.68	348.42
Total Revenue	395.62	418.96	492.68	348.42
Costof Revenue Total	381.90	403.84	472.06	337.79
Gross Profit	13.72	15.12	20.62	10.63
Selling/ General/ Admin Expenses Total	3.00	6.90	0.98	0.40
Depreciation/ Amortization	1.70	1.57	1.99	0.92
Other Operating Expenses Total	6.27	0.00	8.37	5.59
Total Operating Expense	392.86	412.36	483.40	344.70
Operating Income	2.75	6.60	9.28	3.72
Interest Inc( Exp) Net- Non- Op Total	-43.75	1.04	-15.92	-23.18
Other Net	6.96	-0.69	2.34	6.90
Net Income Before Taxes	5.34	6.01	10.03	8.30
Provisionfor Income Taxes	0.66	2.24	3.48	1.79
Net Income After Taxes	4.68	3.77	6.54	6.51
Net Income Before Extra Items	4.68	3.77	6.54	6.51
Net Income	4.68	3.77	6.54	6.51
Total Adjustmentsto Net Income	0.00	0.00	0.00	-
Income Availableto Com Excl Extra Ord	4.68	3.77	6.54	6.51
Income Availableto Com Incl Extra Ord	4.68	3.77	6.54	6.51
Diluted Net Income	4.68	3.77	6.54	6.51
Diluted Weighted Average Shares	2.55	2.53	2.41	2.34
Diluted EPS Excluding Extra Ord Items	1.84	1.49	2.72	2.79
Diluted Normalized EPS	1.84	1.50	2.72	2.79
Unusual Expense( Income)	-	0.05	-	-